Quarterly report pursuant to Section 13 or 15(d)

Net loss per share (Tables)

v3.23.1
Net loss per share (Tables)
3 Months Ended
Mar. 31, 2023
Net loss per share [Abstract]  
Anti-dilutive Securities Excluded from Computation of Net Loss per Share
The following potential common shares were not considered in the computation of diluted net loss per share as their effect would have been anti-dilutive for the three-month periods ended presented below:
 
   
March 31,
 
   
2023
   
2022
 
Series A, Series B, and RDO warrants
   
7,204,299
     
7,282,999
 
Stock options
   
3,601,427
     
2,616,544
 
RSUs     291,584        
Unissued common stock for services
   
     
8,024
 
Former Rexahn warrants
   
60,713
     
66,538
 
Former Rexahn options
   
     
82